Combining Cognitive Training With tDCS to Enhance Memory Inhibition in Young Binge Drinkers
NCT ID: NCT05237414
Last Updated: 2022-11-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
114 participants
INTERVENTIONAL
2019-02-05
2022-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
At Home Brain Stimulation Studies of Memory and Memory Awareness
NCT04749719
Combined tDCS and Cognitive Training to Reduce Impulsivity in Patients With Traumatic Brain Injury
NCT03844607
tDCS and Cognitive Training in Active Duty Service Members With Mild TBI: A Pilot Study
NCT04925453
Effects of Brain-stimulation on Metamemory Monitoring and Control
NCT03693729
The Effect of tES on a Cognitive Training
NCT03475446
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
During this pre-training session, psychological (i.e., craving levels), behavioral (i.e., alcohol consumption, recall accuracy and MI performance), and neurofunctional (i.e., ERPs and FC) variables will be assessed.
In addition, this study aims to evaluate an alcohol-specific MI intervention protocol using cognitive training and tDCS while its effects on behavioral and EEG outcomes are assessed. For that, BDs will be randomly assigned to one of three training groups: combined intervention (active CT and active tDCS applied over the right DLPFC), cognitive intervention (active CT and sham tDCS), or control intervention (sham CT and sham tDCS). Training will occur in three consecutive days (i.e., Tuesday, Wednesday, and Thursday), in three sessions. MI will be re-assessed in BDs after the last training session through a post-training EEG assessment. N/LDs will only perform the pre-training EEG assessment. Alcohol use and craving will also be measured both 10-days and 3-months post-training in order to monitor short- and medium-term effects of the MI training in the alcohol craving and consumption levels. Furthermore, behavioral and EEG data will be collected during the performance of an alcohol cue reactivity (ACR) task before and after the MI training sessions, in order to evaluate potential attentional bias towards alcoholic stimuli. Overall, this intervention protocol aims to investigate whether this training is able 1) to enhance MI capabilities and to reduce alcohol attentional bias, and 2) to decrease craving and/or alcohol use -monitoring up to three months after protocol implementation- in trained BD participants.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Binge Drinkers with Combined Intervention (active CT + active tDCS)
Subjects will perform a variation of the TNTA task (Anderson \& Green, 2001; López-Caneda et al., 2019) to enhance the suppression of alcohol-related memories. The Learning phase will be composed of 2 blocks of 12-image pairs (as there is no a baseline block), and in the TNT phase, all the stimuli to be inhibited will be alcohol-related images. After the Learning Phase, active neuromodulation will be performed using tDCS. Twenty minutes of 2 mA direct current will be applied on the scalp using a saline-soaked pair of 35 cm2 surface sponge electrodes, through an Eldith DC Stimulator Plus (Neuroconn, Germany). To stimulate the right DLPFC, the anodal electrode will be placed over F4 according to the 10-20 international system for EEG electrode placement. The cathode electrode will be over the contralateral supraorbital area. The current fade in for 15 seconds, is constant at 2 mA for 20 minutes, and then fade out for 15 seconds.
Active tDCS
20 minutes of 2.0 mA direct current applied over the right DLPFC
Active CT
Active memory inhibition CT (i.e., training of memory inhibition specifically for alcohol-related memories).
Binge Drinkers with Cognitive Intervention (active CT + sham tDCS)
Subjects perform the variation of the TNTA task for active CT. After the Learning Phase, sham neuromodulation is performed using the same montage of the active tDCS. However, the electric current fade in during 15 seconds until reaching 2 mA, then is constant at 2 mA for 15 seconds and fade out for 15 seconds. There is no current for the rest of the time.
Sham tDCS
15 seconds of 2.0 mA direct current applied over the right DLPFC
Active CT
Active memory inhibition CT (i.e., training of memory inhibition specifically for alcohol-related memories).
Binge Drinkers with Control Intervention (sham CT + sham tDCS)
Subjects will perform a variation of the TNTA task, where the Learning phase also have only two blocks of 12-image pairs. However, in this case the TNT phase is replaced by a Forced-Choice Reaction Time (FCRT) task, during which the participants only must categorize alcoholic and non-alcoholic images answering to the question "What type of beverage was there in the image?" (answer: "Alcoholic drink" or "Non-alcoholic drink"); thus, they do not have to inhibit the memories related to the alcoholic images. During this phase, sham neuromodulation will be performed using the same montage of the active tDCS. The electric current fade in during 15 seconds until reaching 2 mA, then is constant at 2 mA for 15 seconds and fade out for 15 seconds, while a sham memory inhibition CT is performed.
Sham tDCS
15 seconds of 2.0 mA direct current applied over the right DLPFC
Sham CT
Sham memory inhibition CT (i.e., participants have to categorize alcoholic and non-alcoholic images but they do not have to inhibit the memories related to these images).
Non/Low-Drinkers
No intervention.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active tDCS
20 minutes of 2.0 mA direct current applied over the right DLPFC
Sham tDCS
15 seconds of 2.0 mA direct current applied over the right DLPFC
Active CT
Active memory inhibition CT (i.e., training of memory inhibition specifically for alcohol-related memories).
Sham CT
Sham memory inhibition CT (i.e., participants have to categorize alcoholic and non-alcoholic images but they do not have to inhibit the memories related to these images).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-24 years
* Binge Drinkers: report (i) drinking 5 or more drinks on one occasion at least once a month, and (ii) drinking at a speed of at least two drinks per hour during these episodes (which brings blood alcohol concentration to 0.08 gram percent or above).
* Non/Low-Drinkers: report (i) never drinking 5 or more drinks on one occasion and (ii) having an AUDIT score ≤ 4.
Exclusion Criteria
* Alcohol abuse (i.e., AUDIT ≥ 20);
* Consumption of medical drugs with psychoactive effects (e.g., sedatives or anxiolytics) during the two weeks before the experiment;
* Personal history of psychopathological disorders (according to DSM-V criteria);
* History of traumatic brain injury or neurological disorder;
* Family history of alcoholism or diagnosis of other substance abuse;
* Occurrence of one or more episodes of loss of consciousness for more than 20 minutes;
* Non-corrected sensory deficits;
* Global Severity Index (GSI) \> 90 (Symptom Checklist-90-Revised questionnaire \[SCL-90-R\]; Derogatis, 1983) or a score above 90 in at least two of the symptomatic dimensions.
18 Years
24 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minho
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eduardo López-Caneda
Postdoctoral Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eduardo G. López-Caneda, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Minho
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Psychology
Braga, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lopez-Caneda E, Crego A, Campos AD, Gonzalez-Villar A, Sampaio A. The Think/No-Think Alcohol Task: A New Paradigm for Assessing Memory Suppression in Alcohol-Related Contexts. Alcohol Clin Exp Res. 2019 Jan;43(1):36-47. doi: 10.1111/acer.13916. Epub 2018 Nov 25.
Almeida-Antunes N, Anton-Toro L, Crego A, Rodrigues R, Sampaio A, Lopez-Caneda E. Trying to forget alcohol: Brain mechanisms underlying memory suppression in young binge drinkers. Prog Neuropsychopharmacol Biol Psychiatry. 2024 Aug 30;134:111053. doi: 10.1016/j.pnpbp.2024.111053. Epub 2024 Jun 11.
Almeida-Antunes N, Vasconcelos M, Crego A, Rodrigues R, Sampaio A, Lopez-Caneda E. Forgetting Alcohol: A Double-Blind, Randomized Controlled Trial Investigating Memory Inhibition Training in Young Binge Drinkers. Front Neurosci. 2022 Jun 29;16:914213. doi: 10.3389/fnins.2022.914213. eCollection 2022.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CE.CSH 078/2018
Identifier Type: OTHER
Identifier Source: secondary_id
PTDC/PSI-ESP/28672/2017
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
PTDC/PSI-ESP/28672/2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.